PainReform Ltd. (PRFX) vs Sunshine Biopharma, Inc. (SBFM)
PainReform Ltd. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Sunshine Biopharma, Inc. is the larger, with a market value of $3.3M against $3.0M — 1.1× the size. PainReform Ltd. has the higher net margin (0.00% vs −16.5%) and the higher return on invested capital (0.00% vs −26.7%). Across the 14 metrics below, PainReform Ltd. leads on 10 and Sunshine Biopharma, Inc. on 4.
Valuation
| Metric | PRFX | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.14 |
| P/S | n/m | 0.03 | 2.25 |
| P/B | 0.00 | 0.04 | 1.90 |
| Price to free cash flow | n/m | n/m | 16.54 |
| EV/EBITDA | 0.99 | 2.48 | 12.29 |
| EV/Sales | n/m | (0.34) | 2.56 |
| Earnings yield | (61,696.04%) | (1,208.33%) | (2.99%) |
| Free cash flow yield | (80,633.63%) | (482.76%) | 0.00% |
Profitability
| Metric | PRFX | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 30.30% | 53.94% |
| Operating margin | 0.00% | (16.65%) | 0.00% |
| Net margin | 0.00% | (16.50%) | 0.00% |
| Free cash flow margin | 0.00% | (15.66%) | 0.00% |
| Return on equity | 0.00% | (21.93%) | (0.40%) |
| Return on assets | 0.00% | (17.78%) | (3.32%) |
| Return on invested capital | 0.00% | (26.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack